INNO and INNPF Related Headlines

Go Back

Mar 31, 2026 03:00AM Innocan Pharma Reports 2025 Financial Results, with Revenues at US $26.6M

Feb 9, 2026 09:07AM Innocan Pharma Announces LPT-CBD demonstrates Pain Relief over Placebo-Results from a randomized blinded clinical study in Dogs

Jan 27, 2026 04:00PM Innocan Pharma plans NYSE American listing around January 30

Jan 27, 2026 04:00PM Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering

Jan 2, 2026 07:00AM Innocan Pharma anticipates NYSE American listing around January 7

Jan 2, 2026 07:00AM Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering

INNO and INNPF Related Press Releases

Go Back

Mar 31, 2026 03:00AM Innocan Pharma Reports 2025 Financial Results, with Revenues at US $26.6M

Feb 9, 2026 09:07AM Innocan Pharma Announces LPT-CBD demonstrates Pain Relief over Placebo-Results from a randomized blinded clinical study in Dogs

Jan 27, 2026 04:00PM Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering

Jan 2, 2026 07:00AM Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering

INNO and INNPF Related SEC Filings

Go Back

Sep 5, 2025 09:15AM Form FWP INNOCAN PHARMA Corp Filed by: INNOCAN PHARMA Corp

Sep 5, 2025 09:01AM Form F-1/A INNOCAN PHARMA Corp

Aug 4, 2025 03:20PM Form F-1/A INNOCAN PHARMA Corp

Jul 23, 2025 05:14PM Form F-1 INNOCAN PHARMA Corp